Earlier reports have shown that the d120 mutant of herpes simplex virus 1 lacking both copies of the gene encoding the infected cells protein No. 4 (ICP4) induces apoptosis in a variety of cell lines. The programmed cell death induced by this mutant is blocked by overexpression of Bcl-2 or by transduction of infected cells with the gene encoding the viral U S 3 protein kinase. HEp-2 cells infected with the d120 mutant express predominantly ␣ proteins. Studies on these proteins revealed the accumulation of a M r 37,500 protein that reacted with antibody directed against the carboxyl-terminal domain of ICP22. We report that the M r 37,500 protein is a product of the proteolytic cleavage of ICP22 by a caspase activated by the d120 mutant. Thus the accumulation of the M r 37,500 protein was blocked in cells transduced with the U S 3 protein kinase, in cells overexpressing Bcl-2, or in infected cells treated with the general caspase inhibitor zVAD-fmk. Exposure of ICP22 made in wild-type virus-infected cells to caspase 3 yielded two polypeptides, of which one could not be differentiated from the M r 37,500 protein with respect to electrophoretic mobility. We conclude that the cellular apoptotic response targets at least one viral protein for destruction.
INTRODUCTION
Earlier reports have shown that herpes simplex virus 1 (HSV-1) blocks programmed cell death induced by a variety of agents including sorbitol, Fas ligand, tumor necrosis factor ␣, etc. (Asano et al., 1999 (Asano et al., , 2000 Galvan et al., 1999 Galvan et al., , 2000 Galvan and Roizman, 1998; Hata et al., 1999; Jerome et al., 1999; Koyama and Miwa, 1997; Leopardi and Roizman, 1996; Leopardi et al., 1997a; Sieg et al., 1996; Roizman, 2000, 2001) . Whereas wild-type HSV-1 does not induce apoptosis, several mutants have been shown to induce apoptosis in a variety of cell lines (Asano et al., 1999 (Asano et al., , 2000 Galvan et al., 1999 Galvan et al., , 2000 Galvan and Roizman, 1998; Leopardi and Roziman, 1996; Leopardi et al., 1997a; . This article concerns a mutant (d120) that lacks both copies of ␣4, the gene-encoding infected cell protein No. 4 (ICP4), a negative and positive regulator of gene expression. In cells infected with this mutant the ␣ proteins accumulate in large amounts. A major characteristic of the infected cells is extensive cytopathology characteristic of apoptosis (Leopardi and Roizman, 1996) . The d120 mutant induces apoptosis in virtually all cell lines tested to date, although the mechanism by which it induces programmed cell death ap-pears to be cell line dependent (Galvan et al., 1999; Galvan and Roizman, 1998) . In recent studies it has been shown that stable transduction and overexpression of Bcl-2, or transient expression of the U S 3 protein kinase encoded by the HSV-1, blocks the proapoptotic activity of the d120 mutant in HEp-2 cells .
In the course of studying the proteins made in d120 mutant-infected cells, we noted that the antibody to ICP22 reacted with a novel protein with an apparent M r of 37,500. This protein does not accumulate in cells infected with wild-type virus. In this article we show that the M r 37,500 protein is a caspase cleavage product of ICP22. Thus the accumulation of the M r 37,500 protein was blocked in cells transduced with the U S 3 protein kinase, in cells overexpressing Bcl-2, or in cells treated with the general caspase inhibitor zVAD-fmk. Exposure of ICP22 made in wild type-virus infected cells to caspase 3 yield two polypeptides, one of which could not be differentiated from the M r 37,500 protein with respect to electrophoretic electrophoretic mobility.
Relevant to this article are the following: ICP22 is a product of the ␣22 gene. The domain of this gene encodes two polypeptides. ICP22 is translated from an mRNA that is spliced immediately 5Ј of the open reading frame. The U S 1.5 protein is translated from an unspliced message transcribed from sequences contained within the ␣22 open reading frame, and the U S 1.5 ORF is collinear with the middle and carboxyl-terminal domains of the ICP22 ORF (Carter and Roizman, 1996) . Neither ␣22 nor U S 1.5 are essential for viral replication in cultured cells but the mutants lacking the ␣22 gene are highly 1 To whom correspondence and reprint requests should be addressed. Fax: (773) 702-1631 702- . E-mail: bernard@cummings. uchicago.edu. Virology 305, 364-370 (2003 702- ) doi:10.1006 702- /viro.2002 702- .1728 0042-6822/03 $30.00 attenuated in experimental animals (Poffenberger et al., 1994) . The mutants grow as well as wild-type virus in HEp-2 or Vero cells but show a reduced capacity to replicate in primary human cells or rabbit or rodent cells. In these cells the expression of a subset of late (␥ 2 ) genes exemplified by U L 38 and U S 11 is grossly reduced (Ogle and Roizman, 1999; Purves et al., 1993) . A mutant virus expressing the U S 1.5 protein but not ICP22 accumulates amounts of U L 38 and U S 11 proteins similar to that observed in wild-type virus-infected cells but is avirulent in mice (Ogle and Roizman, 1999) . More recent studies have shown that the expression of this subset of late genes is dependent on the presence of both the ␣22/U S 1.5 gene and the protein kinase induced by the U L 13 protein kinase and is mediated by the activation of the cdc2 cyclin-dependent kinase (Advani et al., 2000; Purves et al., 1993) .
RESULTS

Appearance of an additional ICP22 immunoreactive band in lysates of cells infected with the d120 mutant
To examine the specific forms of ICP22 present during various wild-type or mutant HSV infections, HEp-2 cells were mock-infected, infected with HSV-1(F), or infected with either the d120 mutant or R7041 (⌬U S 3). The cells were harvested at 18 h after infection, solubilized, electrophoretically separated in denaturing polyacrylamide gels, transferred to a nitrocellulose sheet, and reacted with antibody raised to the carboxyl-terminal domain of ICP22. As shown in Fig. 1 , abundant expression of ICP22 and to a lesser extent of the U S 1.5 proteins was detected in HSV-1(F), d120, and R7041-infected cells, but not in mock-infected cells. ICP0 was also detected in cells infected with HSV-1(F)-, d120-, and R7041 (data not shown).
An ICP22 immunoreactive band with an apparent M r an apparent M r of approximately 37,500 was abundant in d120-infected cells and to a much lesser extent in R7041 mutant-infected cells but was not detected in HSV-1(F)infected cells (Fig. 1 , compare lane 2 with lanes 3 and 4). The electrophoretic mobility of the M r 37,500 ICP22 immunoreactive protein band is greater than that of the U S 1.5 band that is detectable in lysates of cells infected with HSV-1(F), d120, or R7041 viruses ( Fig. 1 , lanes 2, 3, and 4).
To examine the temporal pattern of appearance of the M r 37,500 protein, HEp-2 cells were mock infected or infected with the d120 mutant, harvested at various times after infection, solubilized, electrophoretically separated in denaturing polyacrylamide gels, transferred to a nitrocellulose sheet, and reacted with antibody raised to the carboxyl-terminal domain of ICP22. As shown in Fig. 2 , the M r 37,500 protein (arrow) was first detected in significant amounts at 15 h (lane 2) and increased in amount by 20 h after infection.
Prevention of d120 induced apoptosis precludes the accumulation of the M r 37,500 protein Two series of experiments were done to test the hypothesis that the M r 37,500 protein arose as a consequence of apoptosis induced by the d120 mutant. In the first series we made use of a HEp-2 cell line (VAX-3) that FIG. 1. Photograph of electrophoretically separated cell lysates reacted with polyclonal rabbit antibody to the carboxy-terminus of ICP22. Replicate 25-cm 2 flask cultures of HEp-2 cells were mock-infected or infected for 18 h at 37°C with 10 PFU of HSV-1(F), d120, R7041, or gD Ϫ/ϩ per cell; harvested; solubilized; electrophoretically separated on denaturing gels; electrically transferred to a nitrocellulose sheet; and reacted with rabbit antibody to the carboxy-terminus of ICP22.
FIG. 2.
Photograph of electrophoretically separated cell lysates reacted with polyclonal rabbit antibody to the carboxy-terminus of ICP22. Replicate 25-cm 2 flask cultures of HEp-2 cells were mock-infected for 18 h or infected with 10 PFU of the d120 mutant per cell, harvested at the indicated time points, solubilized, electrophoretically separated on denaturing gels, electrically transferred to a nitrocellulose sheet, and reacted with rabbit antibody to the carboxy-terminus of ICP22.
overexpresses the bcl-2 protein and blocks d120-induced apoptosis . In addition we tested the effects of the general caspase inhibitor z-VADfmk, which also blocks d120-induced apoptosis in HEp-2 cells . Replicate cultures of the bcl-2 overexpressing cells (VAX-3) or the parent, HEp-2 cells, were either mock infected or infected with HSV-1(F), or the d120 mutant in the presence or absence of 25 or 50 M z-VAD-fmk. The cells were harvested at 18 h after mock infection or infection, solubilized, electrophoretically separated in denaturing polyacrylamide gels, transferred to a nitrocellulose sheet, and reacted with antibody raised to the carboxyl terminus of ICP22. The results shown in Fig. 3 were as follows: The M r 37,500 protein (arrow) accumulated in d120-infected HEp-2 cells in the absence of z-VAD-fmk (lane 3). The protein did not accumulate in HEp-2 cells infected with d120 and maintained in the presence of z-VAD-fmk. The protein also did not accumulate in VAX-3 cells, whether infected with HSV-1(F) or the d120 mutant.
The second series of experiments was based on studies reported earlier that the U S 3 protein kinase blocked apoptosis induced by the d120 mutant at a step upstream of mitochondrial activation . It became of interest to determine if in addition to blocking apoptosis, U S 3 also blocked the accumulation of the M r 37,500 protein. To address this question, HEp-2 cells were either mock infected or infected with the d120 mutant simultaneously with recombinant baculoviruses expressing U S 3 (Bac-U S 3) or U S 5 (Bac-U S 5). The cells were harvested 18 h after infection, solubilized, electrophoretically separated in denaturing polyacrylamide gel, transferred to nitrocellulose sheet, and reacted with an antibody to the carboxyl-terminus of ICP22. As shown in Fig. 4 , cells transduced with Bac-U S 3 and infected with the d120 mutant did not accumulate the M r 37,500 protein (lane 1), whereas the cells infected with d120 alone or in combination with Bac-U S 5 both accumulated the protein (arrow, lanes 2 and 3).
The results of the two series of experiments indicate that the accumulation of the M r 37,500 protein was blocked by overexpression of Bcl-2 in VAX-3 cells, by z-VAD-fmk in d120-mutant-infected HEp-2 cells, and by transduction of the cells with U S 3 protein kinase. Inasmuch as overproduction of Bcl-2 blocks apoptosis induced by the d120 mutant, the results indicate a connection between apoptosis induced by the d120 mutant and appearance of the M r 37,500 protein. The observation is affirmed by the finding that the U S 3 protein kinase also blocks the accumulation of the protein. Last, the observation that z-VAD-fmk also blocks the accumulation of the protein suggests that M r 37,500 is a caspase cleavage product. Inasmuch as both ICP22 and M r 37,500 proteins react with the W2 antibody directed against the carboxyl-terminal region of ICP22, the results suggest that M r 37,500 is the carboxyl-terminal portion of ICP22 cleaved by a caspase that had been activated by the d120 mutant.
FIG. 3. Photograph of electrophoretically separated cell lysates reacted with polyclonal rabbit antibody to the carboxy-terminus of ICP22. Replicate 25-cm 2 flask cultures of HEp-2 or VAX-3 cells were mockinfected or infected with 10 PFU of the HSV-1(F) or the d120 mutant per cell and where indicated, incubated in the presence of z-VAD-fmk. Eighteen hours after infection, cells were harvested, solubilized, electrophoretically separated on denaturing gels, electrically transferred to a nitrocellulose sheet, and reacted with rabbit antibody to the carboxyterminus of ICP22.
FIG. 4.
Photograph of electrophoretically separated cell lysates reacted with polyclonal rabbit antibody to the carboxy-terminus of ICP22. Replicate 25-cm 2 flask cultures of HEp-2 cells were either mockinfected or infected with d120, and where indicated coinfected with Bac-U S 3 or Bac-U S 5. Cultures were harvested 18 h after infection, solubilized, electrophoretically separated on denaturing gels, electrically transferred to a nitrocellulose sheet, and reacted with rabbit antibody to the carboxy-terminus of ICP22.
Cleavage of the precursor of M r 37,500 is a late event blocked by transduction of U S 3 as late as 9 h after infection with the d120 mutant Earlier studies from this laboratory showed that exposure of cells to Bac-U S 3 blocked the processing of procaspase 3 when administered 6 h after d120 infection and had a partial affect when administered as late as 9 h after d120 infection . To determine whether U S 3 prevented the accumulation of the M r 37,500 protein with a similar time frame, HEp-2 cells were exposed to Bac-U S 3 at various times after d120 mutant infection. The cells were harvested at 18 h after infection with the d120 mutant virus, solubilized, electrophoretically separated in denaturing polyacrylamide gels, transferred to a nitrocellulose sheet, and reacted with an antibody to the carboxyl terminus of ICP22. The results (Fig. 5 ) were as follows: The M r 37,500 protein band was detected in cells exposed to d120 only (lane 2), but not in d120-infected cells that had been exposed to Bac-U S 3 at Ϫ3, 0, 3, 6, or 9 h after d120 infection (lanes 3-7). These results indicate that Bac-U S 3 prevented the accumulation of the M r 37,500 protein as late as 9 h after infection. These results are consistent with the earlier observation that U S 3 blocked caspase 3 activation when administered as late as 9 h after infection with the d120 mutant .
ICP22 is a substrate of caspase 3
The results presented above suggested that the M r 37,500 protein is a caspase cleavage product of ICP22. To test the hypothesis that ICP22 is a caspase 3 sub-strate, HEp-2 cells were either mock infected or infected with HSV-1(F) or the d120 mutant, harvested 18 h after infection, homogenized by multiple strokes of a tight Dounce homogenizer, clarified by centrifugation, and treated with exogenous purified caspase 3. The results shown in Fig. 6 were as follows: In the absence of exogenously added caspase 3 HSV-1(F)-infected extracts exhibited abundant full-length ICP22 and no detectable M r 37,500 protein (lane 4). In contrast, HSV-1(F)infected cell extracts that had been treated with exogenous casease 3 (lane 3) exhibited very little full-length ICP22 and accumulated a M r 37,500 protein (a) as well as a M r 35,000 protein (b). In the absence of exogenously added caspase 3 d120 infected cell extracts exhibited full-length ICP22 and the M r 37,500 polypeptide (lane 2), whereas the caspase 3 treated d120 extracts exhibited no detectable full-length ICP22, an increase in the M r 37,500 polypeptide and the appearance of the M r 35,000 polypeptide (Lane 1). ICP22 contains four potential caspase 3 cleavage sites, two of which, DDPD, starting at amino acid 106, and DATD, starting at amino acid 307, are preferred by caspase 3 based upon published caspase 3 cleavage site specificities (Thornberry et al., 1997) . The other two sites, DRRD at amino acid 137 and DTED at amino acid 325, are less preferred (27) . While estimation of the molecular weight of HSV-1 proteins based on electrophoretic migration is wrought with uncertainty because of their high proline content, cleavage at the preferred sites, 107 and 307, could yield polypep-FIG. 5. Photograph of electrophoretically separated cell lysates reacted with polyclonal rabbit antibody to the carboxy-terminus of ICP22. Replicate 25-cm 2 flask cultures of HEp-2 cells were either mockinfected or infected with d120, and where indicated coinfected with Bac-U S 3 at the times relative to d120 infection. Cultures were harvested 18 h after infection, solubilized, electrophoretically separated on denaturing gels, electrically transferred to a nitrocellulose sheet, and reacted with rabbit antibody to the carboxy-terminus of ICP22.
FIG. 6. Photograph of electrophoretically separated cell lysates reacted with polyclonal rabbit antibody to the carboxy-terminus of ICP22. Replicate 25-cm 2 flask cultures of HEp-2 cells were either mockinfected or infected for 18 h at 37°C with 10 PFU of HSV-1(F) or the d120 mutant per cell; harvested, solubilized, and where indicated, treated with caspase 3. Extracts were electrophoretically separated on denaturing gels, electrically transferred to a nitrocellulose sheet, and reacted with rabbit antibody to the carboxy-terminus of ICP22. tides with M r s of 37,500 and 35,000, respectively. These results suggest that ICP22 is cleaved by caspase 3, yielding two polypeptides detectable by the antibody made against the carboxyl-terminal domain of ICP22. The M r 35,000 proteins are most likely either not stable during the course of d120 infection or are cleaved only in vitro since only the M r 37,500 protein is detected during d120 infection.
DISCUSSION
Programmed cell death serves many functions. Foremost, it is a mechanism by which multicellular organisms dispose of unwanted cells. Among the unwanted cells are those that become infected and threaten the destruction of the organism. Viruses and HSV in particular tend to block apoptosis since the self-destruction of the cells decreases viral yield. The objective of the studies done on mutants that induce apoptosis are to identify the viral gene product(s) that induce apoptosis, the mechanisms by which apoptosis is induced, the gene product that blocks apoptosis, and the pathways by which apoptosis is blocked. In the case of the d120 mutant the gene products which induce apoptosis are not known. Although only a few gene products are made after infection, we cannot exclude the possibility that tegument proteins released from the infecting virions contribute to the induction of apoptosis. It is possible that the U S 1.5 protein which is expressed with ␣ kinetics or the U S 13 protein which is contained in the tegument play a role in the induction of apoptosis by the d120 mutants as transduction of U S 1.5 or U L 13 is able to induce apoptosis and induction of apoptosis by U S 1.5 and U L 13 is blocked by contransduction of U S 3 (Hagglund et al., 2002) . Extensive studies on the d120 mutant have shown that the mechanism by which apoptosis is induced is cell type dependent. Apoptosis is caspase independent in d120 mutantinfected SK-N-SH cells and caspase activation dependent in HEp-2 cells (Galvan et al., 1999; Galvan et al., 2000) . Recent reports from this laboratory have shown that U S 3 protein kinase blocks apoptosis induced by the d120 mutant (Leopardi et al., 1997; , that it acts upstream of mitochondrial activation , that in rabbit skin cells a target of the U S 3 protein kinase is the BAD proapoptotic member of the Bcl-2 family . Finally, the U S 3 protein kinase in the absence of other viral proteins blocked the activation of caspases in cells transduced with BAD .
The objective of the studies described in this article were to examine in detail the fate distribution and function of the ␣ proteins-the major viral gene products made in the d120-mutant-infected cells. Earlier studies have shown that in cells infected with the d120 mutant ICP0, a promiscuous transactivator product of the ␣0 gene, is transported to the cytoplasm where it aggre-gates with proteosome subunits into dense cytoplasmic structures. The focus of the studies that led to this report was on ICP22. In the course of these studies we noted the appearance of a protein of M r 37,500 antigenically related to ICP22. The studies described in this article show that the M r 37,500 protein is the product of proteolytic cleavage of ICP22 caused by activation of caspases. Specifically, we have shown that the M r 37,500 protein does not accumulate in HEp-2 cells overexpressing Bcl-2 (VAX-3 cells), in cells transduced with the U S 3 protein kinase, or in cells treated with z-VAD-fmk-a generalized caspase inhibitor. In addition, we have shown that an antigenically related protein identical in electrophoretic mobility to the M r 37,500 was produced by the digestion of wild-type virus lysates with exogeneously added caspase 3. The product of digestion also included a second protein antigenically related to ICP22 and with an apparent M r of 35,000. This protein is either a product of digestion by another enzyme activated by caspase 3 or a protein that is rapidly degraded in d120-infected cells.
It is noteworthy that less of the M r 37,500 protein accumulated in cells infected with the R7041 mutant than in cells infected with the d120 mutant. The accumulation of the ICP22 cleavage product thus appears to correlate with the ability of the virus to induce apoptosis, inasmuch as R7041 induces significantly less caspase 3 activity than the d120 mutant (data not shown).
Earlier studies have indicated that multiple isoforms of the U S 1.5 protein ranging in molecular weight from M r 35,000 to 48,000 also react with the W2 antibody (Ogle and Roizman, 1999; Hagglund et al., 2002) . Thus, it is possible that the M r 37,500 protein corresponds to a novel U S 1.5 isoform expressed in cells infected with the d120 mutant but not wild-type virus. However, this explanation is unlikely because the addition of exogenous caspase 3 to lysates of cells infected with wild-type virus produces the identical M r 37,500 band and loss of ICP22, indicating that the M r 37,500 protein is produced as a result of cleavage of ICP22 by caspase 3.
Of particular interest is the observation that cells transduced by baculoviruses encoding the U S 3 protein kinase as late as 9 h after infection blocked activation of caspases and also the accumulation of the M r 37,500 protein. These studies indicate that apoptosis induced by the d120 mutant is induced many hours after infection and becomes manifest by the activation of caspases.
To our knowledge ICP22 is the first HSV-1 protein shown to be cleaved by caspases induced by proapoptotic mutants. While we have not excluded the possibility that other viral proteins are degraded as a consequence of induction of programmed cell death, the significance of the cleavage of ICP22 remains unclear. Viruses do not evolve proteins to be cleaved by caspases to diminish the yield of viral progeny. Furthermore, they could be expected to evolve amino acid substitutions that preclude proteolytic degradation if production of viral prog-eny was at stake. There are many examples of cellular caspase substrates whose activity changes drastically upon caspase cleavage, and one could imagine scenarios in which caspase-mediated cleavage of ICP22 might alter its activity and thus the course of infection to benefit the virus if it were to infect an apoptotic cell. However, it remains to be determined whether the M r 37,500 plays a role in the biology of the infected cell.
MATERIALS AND METHODS
Cells and viruses
HEp-2 cells were obtained from the American Type Culture Collection (Rockville, MD) and grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% newborn calf serum. The creation of the VAX3 cell line was previously described . HSV-1(F) is the prototype HSV-1 strain used in the laboratory (Ejercito et al., 1968) . The HSV-1(KOS) d120 mutant, a kind gift of N. Deluca, lacks both copies of the ␣4 gene and was grown in a Vero-derived cell line (E5) expressing the ␣4 gene (DeLuca et al., 1985) . The recombinant virus R7041 lacks the PstI-BamHI fragment encoding amino acids 69 to 357 of the U S 3 gene (Purves et al., 1987) .
Baculoviruses
The construction of Bac-U S 3 and Bac-U S 5, recombinant baculoviruses expressing U S 3 and glycoprotein J, respectively, was described elsewhere . Briefly, the U S 5 or U S 3 ORF was cloned into the MTS-1 transfer vector and cotransfected with baculogold DNA (Pharmingen, San Diego, CA) to create a recombinant baculovirus that expresses either U S 3 or U S 5 under the control of the constitutive CMV promoter. Efficient baculovirus gene expression in mammalian cells requires treatment with sodium butyrate, a histone deacetylase inhibitor (Condreay et al., 1999) . In all experiments in which HEp-2 cells were infected with baculoviruses, all infected or treated cultures were exposed to medium containing 10 mM sodium butyrate after 2 h of incubation at 37°C with approximately 15 PFU of the indicated recombinant baculoviruses per cell.
Immunoblots
Cells were scraped into their medium, pelleted by low speed centrifugation, rinsed twice with PBS A (0.14 M NaCl, 3 mM KCl, 10 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 ), lysed in RIPA buffer [1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS in PBS A containing a protease inhibitor cocktail (Roche Pharmaceuticals, Nutley, NJ)], and stored on wet ice for 10 min before centrifugation at 14,000 g for 10 min. The protein concentration of the supernatant fluids was determined with the aid of the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA) according to direc-tions provided by the manufacturer. Samples containing 75 g of protein each were denatured in disruption buffer (50 mM Tris pH 7.0, 2.75% sucrose, 5% ␤-mercaptoethanol, 2% sodium dodecylsulfate), boiled for 5 min, electrophoretically separated in a 12% denaturing polyacrylamide gel, electrically transferred to a nitrocellulose sheet, blocked, and reacted with a 1:3000 dilution of W2, a rabbit polyclonal antibody specific for the carboxyl terminus of ICP22/U S 1.5 described elsewhere (Leopardi et al., 1997b) .
Caspase 3 cleavage assay
HEp-2 cells grown in roller bottle cultures were either mock infected or infected with 10 PFU of HSV-1(F) or the d120 mutant virus per cell. Where indicated, the cells were infected with 10 PFU of HSV-1(F) or the d120 mutant per cell. After 18 h of infection, the cells were collected and resuspended in ice-cold buffer A [20 mM HEPES, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 250 mM sucrose, and 0.1 mM phenylmethylsulfonyl fluoride (PMSF) to a volume of approximately 10ϫ the cell pellet]. After 15 min on ice, the cells were homogenized in a Dounce homogenizer and then centrifuged for 10 min at 750 g to remove unlysed cells and nuclei. The supernatant fluids were transferred to new tubes and centrifuged again at 10,000 g for 20 min. The extract (80 l) was then treated with 20 ng caspase 3 (Biomol, Plymouth Meeting, PA) where indicated and subsequently incubated at 37°C for 90 min before stopping the reaction with disruption buffer.
